Hematological Malignancies & Bone Marrow Transplantation
Our BMT program is one of the 16 core centers that comprise the NHLBI/NCI Blood and Marrow Transplant Clinical Trials Network. The BMT program works closely with the UFSCC Stem Cell Biology Group to identify new applications for stem cell therapies and with the UF Diabetes Center to explore immunotherapies for diabetes. The UF BMT program strives to develop and test new therapeutic strategies for patient with hematological malignancies, while advancing the understanding of normal stem cell biology. Optimization of outcomes of blood and marrow transplantation and the intensive study of the biology of hematological malignancies is also a key objective. Our well-known and highly-specialized faculty, each with specific areas of investigation, have taken the UF BMT program to the next level of innovation and patient care, supported by the 20-bed dedicated inpatient unit, a contiguous outpatient clinic, stem cell laboratory, core blood tissue bank and stem cell collection facility.